Krystal Biotech Inc (KRYS)
Number of days of payables
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Payables turnover | 22.81 | 18.74 | 18.36 | 18.26 | 23.36 | 21.98 | 20.61 | 20.35 | 19.04 | 11.39 | 5.99 | 5.75 | 4.64 | 6.61 | 20.91 | 10.83 | 6.52 | 4.70 | 5.61 | 11.65 | |
| Number of days of payables | days | 16.00 | 19.47 | 19.89 | 19.99 | 15.62 | 16.60 | 17.71 | 17.94 | 19.17 | 32.05 | 60.98 | 63.51 | 78.72 | 55.22 | 17.45 | 33.70 | 55.96 | 77.69 | 65.05 | 31.33 |
December 31, 2024 calculation
Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ 22.81
= 16.00
The number of days of payables for Krystal Biotech Inc has shown fluctuations over the reporting periods. The company's payables were relatively stable around 50-60 days during most of 2020 and 2021. However, there was a significant decrease in the number of days of payables in the first half of 2022, reaching a low of around 17 days. This indicates that the company was able to manage its payables more efficiently during this period.
Subsequently, the number of days of payables slightly increased in the second half of 2022 and remained relatively stable around 20 days up to the end of 2024. This stability suggests that the company may have refined its payment processes and maintained consistent payment terms with its suppliers.
Overall, the trend in the number of days of payables for Krystal Biotech Inc reflects a mix of efficient management of payables and stable payment practices over the analyzed periods, indicating a balanced approach to managing its supplier obligations.
Peer comparison
Dec 31, 2024